SPOTLIGHT -
EP. 1: Incidence and Subtypes of Advanced Soft Tissue Sarcoma
EP. 2: Accurately Diagnosing Soft Tissue Sarcoma
EP. 3: Multidisciplinary Assessment of Soft Tissue Sarcomas
EP. 4: Implementation of Multidisciplinary Sarcoma Care
EP. 5: Key Members of the Multidisciplinary Team
EP. 6: Integrating Community Oncologists Into the Multidisciplinary Team
EP. 7: Importance of Surgery and Radiation in Advanced STS
EP. 8: Chemotherapy Regimens for Advanced Soft Tissue Sarcoma
EP. 9: Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma
EP. 10: Subtyping in Soft Tissue Sarcoma: The PALLETTE Study
EP. 11: Use of Trabectedin in Soft Tissue Sarcoma
EP. 12: Patient Selection in Soft Tissue Sarcoma
EP. 13: Early Data With Olaratumab in Soft Tissue Sarcoma
EP. 14: Phase III Data on Eribulin in Advanced STS
EP. 15: Future Directions in Soft Tissue Sarcoma
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
